Ann Hepatobiliary Pancreat Surg.  2019 Feb;23(1):91-95. 10.14701/ahbps.2019.23.1.91.

Surgery for metastatic renal cell carcinoma in the pancreatic head: A case report and literature review

• Jo S
• Yang IJ
• Song S

• KMID: 2439055
• DOI: http://doi.org/10.14701/ahbps.2019.23.1.91

Abstract

Malignant tumors that metastasize to the pancreas are rare. Among them, renal cell carcinoma is the most common. Surgical resection is more effective in treatment for patients with pancreatic metastasis from renal cell carcinoma, although targeted therapy is applied, to advanced renal cell carcinoma. It is essential to know exact medical history of the patient, because metastasis can occur late after nephrectomy. Surgical procedure may vary, depending on location and number of tumors. We report a case of resection of a pancreatic head tumor, 20 years after nephrectomy due to renal cell carcinoma.

Keyword

Pancreatic neoplasm; Carcinoma; Renal cell; Pancreatectomy

MeSH Terms

Carcinoma, Renal Cell*
Head*
Humans
Neoplasm Metastasis
Nephrectomy
Pancreas
Pancreatectomy
Pancreatic Neoplasms

Figure

• 

  Fig. 1 Axial (A) and coronal (B) contrast-enhanced computed tomography scan images. Computed tomography scan shows a 5 cm well-defined hypervascular heterogeneous lesion and another 2.2 cm round enhancing mass in the right retroperitoneum along the 2nd duodenal portion. This mass involves the pancreatic head.

• 

  Fig. 2 T2-weighted fat-saturated magnetic resonance imaging finding. Two variable-size hypervascular mass lesions in the pancreatic head and right retroperitoneum suggested metastatic lymph node enlargement, from primary hypervascular mass lesion, such as renal cell and neuroendocrine carcinomas.

• 

  Fig. 3 Positron emission tomography-computed tomography finding. About 5.2 cm-sized mass-like lesion with mild fluorodeoxyglucose uptake (maximum standardized uptake value derived for lean body [SULmax] 1.9) in and around the right retroperitoneal area.

• 

  Fig. 4 Macroscopic appearance of the resected specimen.

Reference

1. Flanigan RC, Campbell SC, Clark JI, Picken MM. Metastatic renal cell carcinoma. Curr Treat Options Oncol. 2003; 4:385–390.

2. Zerbi A, Ortolano E, Balzano G, Borri A, Beneduce AA, Di Carlo V. Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol. 2008; 15:1161–1168.

3. Sweeney AD, Wu MF, Hilsenbeck SG, Brunicardi FC, Fisher WE. Value of pancreatic resection for cancer metastatic to the pancreas. J Surg Res. 2009; 156:189–198.

4. Ballarin R, Spaggiari M, Cautero N, De Ruvo N, Montalti R, Longo C, et al. Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol. 2011; 17:4747–4756.

5. Moletta L, Milanetto AC, Vincenzi V, Alaggio R, Pedrazzoli S, Pasquali C. Pancreatic secondary lesions from renal cell carcinoma. World J Surg. 2014; 38:3002–3006.

6. Hasan MK, Hawes RH. EUS-guided FNA of solid pancreas tumors. Gastrointest Endosc Clin N Am. 2012; 22:155–167. vii

7. Tosoian JJ, Cameron JL, Allaf ME, Hruban RH, Nahime CB, Pawlik TM, et al. Resection of isolated renal cell carcinoma metastases of the pancreas: outcomes from the Johns Hopkins Hospital. J Gastrointest Surg. 2014; 18:542–548.

8. Conti SL, Thomas IC, Hagedorn JC, Chung BI, Chertow GM, Wagner TH, et al. Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. Int J Cancer. 2014; 134:2245–2252.

9. Pal SK, Nelson RA, Vogelzang N. Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy era. PLoS One. 2013; 8:e63341.

10. Schwarz L, Sauvanet A, Regenet N, Mabrut JY, Gigot JF, Housseau E, et al. Long-term survival after pancreatic resection for renal cell carcinoma metastasis. Ann Surg Oncol. 2014; 21:4007–4013.

11. Konstantinidis IT, Dursun A, Zheng H, Wargo JA, Thayer SP, Fernandez-del Castillo C, et al. Metastatic tumors in the pancreas in the modern era. J Am Coll Surg. 2010; 211:749–753.

12. Jakubowski CD, Vertosick EA, Untch BR, Sjoberg D, Wei E, Palmer FL, et al. Complete metastasectomy for renal cell carcinoma: comparison of five solid organ sites. J Surg Oncol. 2016; 114:375–379.

13. Wiltberger G, Bucher JN, Krenzien F, Benzing C, Atanasov G, Schmelzle M, et al. Extended resection in pancreatic metastases: feasibility, frequency, and long-term outcome: a retrospective analysis. BMC Surg. 2015; 15:126.

14. Benhaim R, Oussoultzoglou E, Saeedi Y, Mouracade P, Bachellier P, Lang H. Pancreatic metastasis from clear cell renal cell carcinoma: outcome of an aggressive approach. Urology. 2015; 85:135–140.

15. Rückert F, Distler M, Ollmann D, Lietzmann A, Birgin E, Teoule P, et al. Retrospective analysis of survival after resection of pancreatic renal cell carcinoma metastases. Int J Surg. 2016; 26:64–68.

16. Yagi T, Hashimoto D, Taki K, Yamamura K, Chikamoto A, Ohmuraya M, et al. Surgery for metastatic tumors of the pancreas. Surg Case Rep. 2017; 3:31.

17. Cheong D, Rho SY, Kim JH, Kang CM, Lee WJ. Laparoscopic pancreaticoduodenectomy for renal cell carcinoma metastasized to ampulla of Vater: a case report and literature review. Ann Hepatobiliary Pancreat Surg. 2018; 22:83–89.

18. Chatzizacharias NA, Rosich-Medina A, Dajani K, Harper S, Huguet E, Liau SS, et al. Surgical management of hepato-pancreatic metastasis from renal cell carcinoma. World J Gastrointest Oncol. 2017; 9:70–77.